First Trust AlphaDEX US Health Care (FHH:CA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the First Trust AlphaDEX US Health Care stock forecast from 0 analysts, the average analyst target price for First Trust AlphaDEX US Health Care is not available over the next 12 months. First Trust AlphaDEX US Health Care’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of First Trust AlphaDEX US Health Care is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, First Trust AlphaDEX US Health Care’s stock price was CAD 40.05. First Trust AlphaDEX US Health Care’s stock price has changed by -2.84% over the past week, -2.05% over the past month and +8.92% over the last year.
No recent analyst target price found for First Trust AlphaDEX US Health Care
No recent average analyst rating found for First Trust AlphaDEX US Health Care
Company Overview First Trust AlphaDEX US Health Care
The First Trust ETF seeks to replicate, to the extent possible, the performance of the StrataQuant® Health Care Index (Index), net of expenses. The investment strategy of the First Trust ETF is to invest in and hold the Constituent Securities of the applicable Index in the same proportion as they are reflected in the Index or securities intended to replicate the performance of such Index. The Index results from applying the AlphaDEX" methodology to the Russell 1000® Index, a market index representing the large capitalization segment of the U.S. equity universe, and then selecting the Constituent Securities for the Index from those qualifying stocks included in the Health Care Sector. Read Less
The First Trust ETF seeks to replicate, to the extent possible, the performance of the StrataQuant® Health Care Index (Index), net of expenses. The investment strategy of the First Trust ETF is to invest in and hold the Constituent Securities of the applicable Index in the same ...Read More
Frequently Asked Questions About First Trust AlphaDEX US Health Care (FHH:CA) Stock
Stock Target Advisor's fundamental analysis for First Trust AlphaDEX US Health Care's stock is Very Bearish.
FHH:CA stock's dividend yield is 0.29%.
Our analysis grades FHH:CA stock's dividend yield at F. This means that FHH:CA stock's dividend yield is above 16% of the stocks in the Sector Equity sector in the TSX exchange.
Based on this FHH:CA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on FHH:CA's stock to indicate what its average analyst target is.
FHH:CA stock's Price/Earning ratio is 18.75.
Our analysis grades FHH:CA stock's Price / Earning ratio at D+. This means that FHH:CA stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Sector Equity sector in the TSX exchange.
Based on this FHH:CA may be fairly valued for its sector
The last closing price of FHH:CA's stock was CAD 40.05.
The most recent market capitalization for FHH:CA is CAD 0.01B.
Unfortunately we do not have enough analyst data on FHH:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains First Trust AlphaDEX US Health Care's stock.
As per our most recent records First Trust AlphaDEX US Health Care has 0 Employees.
Sorry we do not have any infomation available on First Trust AlphaDEX US Health Care's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Frequently Asked Questions About First Trust AlphaDEX US Health Care (FHH:CA) Stock
Stock Target Advisor's fundamental analysis for First Trust AlphaDEX US Health Care's stock is Very Bearish.
FHH:CA stock's dividend yield is 0.29%.
Our analysis grades FHH:CA stock's dividend yield at F. This means that FHH:CA stock's dividend yield is above 16% of the stocks in the Sector Equity sector in the TSX exchange.
Based on this FHH:CA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on FHH:CA's stock to indicate what its average analyst target is.
FHH:CA stock's Price/Earning ratio is 18.75.
Our analysis grades FHH:CA stock's Price / Earning ratio at D+. This means that FHH:CA stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Sector Equity sector in the TSX exchange.
Based on this FHH:CA may be fairly valued for its sector
The last closing price of FHH:CA's stock was CAD 40.05.
The most recent market capitalization for FHH:CA is CAD 0.01B.
Unfortunately we do not have enough analyst data on FHH:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains First Trust AlphaDEX US Health Care's stock.
As per our most recent records First Trust AlphaDEX US Health Care has 0 Employees.
Sorry we do not have any infomation available on First Trust AlphaDEX US Health Care's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FHH:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
